Advertisement

Topics

Search Results for "Tingkatan Satu Sejarah Nota"

09:20 EST 8th February 2016 | BioPortfolio

Matching Channels

None

Matching News

NJ Sharing Network 17th Annual Golf Classic at Baltusrol Golf Club Supports Life-Saving Mission of Organ and Tissue Donation

New Providence, NJ (PRWEB) September 29, 2015 For Jill Morton, the opportunity to play at the 17th Annual NJ Sharing Network Golf Cl...

Etymotic Brings Hearing Health Solutions To The Drum Corps International Season Finale

Elk Grove Village, IL (PRWEB) August 19, 2015 The roar of the crowd attending the Drum Corps International World Championships at Lu...

ValiRx arranges £2.45mln finance for development work

Drug developer ValiRx (LON:VAL) has raised £2.45mln through a subscription arrangement with financier Yorkville. The arrangement involves a share subscription at 30.018p per share with the proceeds...

ValiRx: Bioscience Innovation

In this interview, filmed during BioEurope 2008 in Madrid, Fintan Walton speaks with Satu Vainikka, CEO of ValiRx, an AIM listed biopharmaceutical company based in the UK. Focusing on epigenetics, Val...

ValiRx sets up in Boston to strengthen investor base

Cancer drug developer ValiRx (LON:VAL) has established a US operation in Cambridge, Massachusetts and beefed up its US advisory team.  The aim is to encourage interaction with academic, clinica...

ValiRx to collaborate on gene silencing tech

Drug developer ValiRx (LON:VAL) has signed a three-year collaboration agreement with Finnish contract research company Pharmatest to develop products using gene silencing platform GeneICE. No money ...

ValiRx to collaborate with Finnish group using gene silencing tech

Drug developer ValiRx (LON:VAL) has signed a three-year collaboration agreement with Finnish contract research company Pharmatest to develop products using gene silencing platform GeneICE. No money ...

ValiRx signs collaboration deal with Leeds University

Cancer drug developer ValiRx (LON:VAL) has signed a new collaborative research project with Professor Paul Taylor, the co-inventor of one of its two treatments currently going through clinical trials....

Matching PubMed Articles

Development of a Novel PET Tracer 18FAlF-NOTA-C6 Targeting MMP2 for Tumor Imaging.

The overexpression of gelatinases, that is, matrix metalloproteinase MMP2 and MMP9, has been associated with tumor progression, invasion, and metastasis. To image MMP2 in tumors, we developed a novel ...

Development and characterization of an αvβ6-specific diabody and a disulfide-stabilized αvβ6-specific cys-diabody.

This work describes the development and characterization of two antibody fragments that specifically target the αvβ6 integrin, a non-covalent diabody and a disulfide-stabilized cys-diabody. The diab...

EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging Study.

AbstractNoninvasive imaging is a critical technology for diagnosis, classification, and subsequent treatment planning for patients with glioblastoma. It has been shown that the EphA2 receptor tyrosine...

The Influence of the Combination of Carboxylate and Phosphinate Pendant Arms in 1,4,7-Triazacyclononane-Based Chelators on Their 68Ga Labelling Properties.

In order to compare the coordination properties of 1,4,7-triazacyclononane (tacn) derivatives bearing varying numbers of phosphinic/carboxylic acid pendant groups towards 68Ga, 1,4,7-triazacyclononane...

Synthesis and in vivo PET Imaging of Hyaluronan Conjugates of Oligonucleotides.

Synthesis for 68Ga-labelled 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA)-chelated oligonucleotide hyaluronan (HA) tetra- and hexasaccharide conjugates is described. A solid-supported technique ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement